233 related articles for article (PubMed ID: 8455072)
21. Identification of early recurrence of primary central nervous system tumors by [18F]fluorodeoxyglucose positron emission tomography.
Glantz MJ; Hoffman JM; Coleman RE; Friedman AH; Hanson MW; Burger PC; Herndon JE; Meisler WJ; Schold SC
Ann Neurol; 1991 Apr; 29(4):347-55. PubMed ID: 1929205
[TBL] [Abstract][Full Text] [Related]
22. Evaluating contrast-enhancing brain lesions in patients with AIDS by using positron emission tomography.
Pierce MA; Johnson MD; Maciunas RJ; Murray MJ; Allen GS; Harbison MA; Creasy JL; Kessler RM
Ann Intern Med; 1995 Oct; 123(8):594-8. PubMed ID: 7677300
[TBL] [Abstract][Full Text] [Related]
23. [Imagery of human immunodeficiency virus (HIV) encephalitis].
Brugières P; Combes C; Ricolfi F; Houhou S; Sadik JC; Thomas P; Gray F; Gaston A
J Neuroradiol; 1995 Sep; 22(3):163-8. PubMed ID: 7472531
[TBL] [Abstract][Full Text] [Related]
24. Studies of primary central nervous system lymphoma with fluorine-18-fluorodeoxyglucose positron emission tomography.
Rosenfeld SS; Hoffman JM; Coleman RE; Glantz MJ; Hanson MW; Schold SC
J Nucl Med; 1992 Apr; 33(4):532-6. PubMed ID: 1552337
[TBL] [Abstract][Full Text] [Related]
25. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
[TBL] [Abstract][Full Text] [Related]
26. Differentiation of residual or recurrent tumors from post-treatment changes with F-18 FDG PET.
Kim EE; Chung SK; Haynie TP; Kim CG; Cho BJ; Podoloff DA; Tilbury RS; Yang DJ; Yung WK; Moser RP
Radiographics; 1992 Mar; 12(2):269-79. PubMed ID: 1561416
[TBL] [Abstract][Full Text] [Related]
27. Brain metastases from non-central nervous system tumors: evaluation with PET.
Griffeth LK; Rich KM; Dehdashti F; Simpson JR; Fusselman MJ; McGuire AH; Siegel BA
Radiology; 1993 Jan; 186(1):37-44. PubMed ID: 8416584
[TBL] [Abstract][Full Text] [Related]
28. Imaging in Differentiating Cerebral Toxoplasmosis and Primary CNS Lymphoma With Special Focus on FDG PET/CT.
Marcus C; Feizi P; Hogg J; Summerfield H; Castellani R; Sriwastava S; Marano GD
AJR Am J Roentgenol; 2021 Jan; 216(1):157-164. PubMed ID: 33112669
[No Abstract] [Full Text] [Related]
29. Use of fluorodeoxyglucose-positron emission tomography for the differentiation of cerebral lesions in patients with acquired immune deficiency syndrome.
Menendez JA; Lilien DL; Nanda A; Polin RS
Neurosurg Focus; 2000 Feb; 8(2):e2. PubMed ID: 16869549
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic accuracy and predictive value of 201T1 SPET for the differential diagnosis of cerebral lesions in AIDS patients.
D'Amico A; Messa C; Castagna A; Zito F; Galli L; Pepe G; Lazzarin A; Lucignani G; Fazio F
Nucl Med Commun; 1997 Aug; 18(8):741-50. PubMed ID: 9293505
[TBL] [Abstract][Full Text] [Related]
31. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
32. Diagnostic yield of stereotactic brain biopsy guided by positron emission tomography with [18F]fluorodeoxyglucose.
Levivier M; Goldman S; Pirotte B; Brucher JM; Balériaux D; Luxen A; Hildebrand J; Brotchi J
J Neurosurg; 1995 Mar; 82(3):445-52. PubMed ID: 7861223
[TBL] [Abstract][Full Text] [Related]
33. CNS involvement in AIDS: spectrum of CT and MR findings.
Thurnher MM; Thurnher SA; Schindler E
Eur Radiol; 1997; 7(7):1091-7. PubMed ID: 9265682
[TBL] [Abstract][Full Text] [Related]
34. Use of [18F]fluorodeoxyglucose positron emission tomography in patients with primary malignant brain tumors.
Janus TJ; Kim EE; Tilbury R; Bruner JM; Yung WK
Ann Neurol; 1993 May; 33(5):540-8. PubMed ID: 8498831
[TBL] [Abstract][Full Text] [Related]
35. Diagnostic value of kinetic analysis using dynamic 18F-FDG-PET in patients with malignant primary brain tumor.
Kimura N; Yamamoto Y; Kameyama R; Hatakeyama T; Kawai N; Nishiyama Y
Nucl Med Commun; 2009 Aug; 30(8):602-9. PubMed ID: 19521265
[TBL] [Abstract][Full Text] [Related]
36. SPECT thallium-201 combined with Toxoplasma serology for the presumptive diagnosis of focal central nervous system mass lesions in patients with AIDS.
Skiest DJ; Erdman W; Chang WE; Oz OK; Ware A; Fleckenstein J
J Infect; 2000 May; 40(3):274-81. PubMed ID: 10908023
[TBL] [Abstract][Full Text] [Related]
37. [The role of brain magnetic resonance studies in the diagnostics of central nervous system lesions in HIV-1 positive patients].
Sokolska V; Knysz B; Czapiga E; Gasiorowski J; Sasiadek M; Gładysz A
Wiad Lek; 2006; 59(11-12):805-13. PubMed ID: 17427496
[TBL] [Abstract][Full Text] [Related]
38. PET of malignant cerebral tumors after interstitial brachytherapy. Demonstration of metabolic activity and correlation with clinical outcome.
Valk PE; Budinger TF; Levin VA; Silver P; Gutin PH; Doyle WK
J Neurosurg; 1988 Dec; 69(6):830-8. PubMed ID: 2848111
[TBL] [Abstract][Full Text] [Related]
39. MR and TL-210 spect imaging with pathologic correlation for the assessment of CNS lymphoma vs. toxoplasmosis in AIDS patients.
Ketonen L; De la Peña RC; Villanueva-Meyer J
J NeuroAIDS; 1998; 2(1):21-42. PubMed ID: 16873183
[TBL] [Abstract][Full Text] [Related]
40. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities.
Lowe VJ; Hoffman JM; DeLong DM; Patz EF; Coleman RE
J Nucl Med; 1994 Nov; 35(11):1771-6. PubMed ID: 7965154
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
